David A Ford Intercept Pharmaceuticals, Inc. (ICPT) insider trading activity

David A Ford is Chief Human Resources Officer of INTERCEPT PHARMACEUTICALS, INC.. Currently has a direct ownership of 0 shares of ICPT, which is worth approximately $0. The most recent transaction as insider was on Nov 08, 2023, when has been sold 21,400 shares (Common Stock) at a price of $19.0 per share, resulting in proceeds of $406,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

David A Ford Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 08 2023	SELL Sale (or disposition) back to the issuer	$406,600 $19.0 p/Share	21,400 Reduced 100.0%	0 Common Stock
Nov 08 2023	SELL Disposition due to a tender of shares in a change of control transaction	$285,722 $19.0 p/Share	15,038 Reduced 100.0%	0 Common Stock
Jan 27 2023	BUY Grant, award, or other acquisition	-	9,800 Added 21.19%	36,438 Common Stock
Dec 31 2022	SELL Payment of exercise price or tax liability	$21,981 $12.37 p/Share	1,777 Reduced 6.25%	26,638 Common Stock
Jan 27 2022	BUY Grant, award, or other acquisition	-	6,600 Added 18.85%	28,415 Common Stock
Jan 01 2022	SELL Payment of exercise price or tax liability	$1,727 $16.29 p/Share	106 Reduced 0.48%	21,815 Common Stock
Dec 31 2021	SELL Payment of exercise price or tax liability	$26,162 $16.29 p/Share	1,606 Reduced 6.83%	21,921 Common Stock
Oct 01 2021	SELL Payment of exercise price or tax liability	$1,400 $15.22 p/Share	92 Reduced 0.39%	23,527 Common Stock
Jul 01 2021	SELL Payment of exercise price or tax liability	$1,883 $20.47 p/Share	92 Reduced 0.39%	23,619 Common Stock
May 08 2021	SELL Payment of exercise price or tax liability	$2,195 $17.15 p/Share	128 Reduced 0.54%	23,711 Common Stock
Apr 01 2021	SELL Payment of exercise price or tax liability	$2,234 $24.28 p/Share	92 Reduced 0.38%	23,839 Common Stock
Feb 08 2021	SELL Payment of exercise price or tax liability	$5,334 $36.04 p/Share	148 Reduced 0.61%	23,931 Common Stock
Jan 22 2021	BUY Grant, award, or other acquisition	-	11,500 Added 32.32%	24,079 Common Stock
Jan 01 2021	SELL Payment of exercise price or tax liability	$2,618 $24.7 p/Share	106 Reduced 0.84%	12,579 Common Stock
Dec 31 2020	SELL Payment of exercise price or tax liability	$15,536 $24.7 p/Share	629 Reduced 4.72%	12,685 Common Stock
Nov 08 2020	SELL Payment of exercise price or tax liability	$3,603 $28.15 p/Share	128 Reduced 0.95%	13,314 Common Stock
Oct 01 2020	SELL Payment of exercise price or tax liability	$3,871 $42.08 p/Share	92 Reduced 0.68%	13,442 Common Stock

Also insider at

PRTA

PROTHENA CORP PUBLIC LTD CO Healthcare

Chief People Officer

DAF

David A Ford

Chief Human Resources Officer

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ICPT shares.

Notify only if

Value

Insider Trading

Get notified when an Intercept Pharmaceuticals, Inc. insider buys or sells ICPT shares.

Notify only if

Operation

Value

Type

News

Receive news related to INTERCEPT PHARMACEUTICALS, INC.

Account